DrugPatentWatch Database Preview
Details for Patent: 8,431,615
» See Plans and Pricing
Which drugs does patent 8,431,615 protect, and when does it expire?
Patent 8,431,615 protects INCIVEK and is included in one NDA.
This patent has twenty patent family members in thirteen countries.
This patent has expired prematurely due to non-payment of maintenance fees. See details below.
Summary for Patent: 8,431,615
| Title: | Dose forms |
| Abstract: | The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs. |
| Inventor(s): | Chu; Hui-May (Natick, MA), Ette; Ene (Framingham, MA), McNair; Lindsay (Allston, MA), Alam; John (Cambridge, MA) |
| Assignee: | Vertex Pharmaceuticals Incorporated (Cambridge, MA) |
| Application Number: | 11/264,746 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,431,615
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharms | INCIVEK | telaprevir | TABLET;ORAL | 201917-001 | May 23, 2011 | DISCN | No | No | Start Trial | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,431,615
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005302361 | Start Trial | |||
| Canada | 2585647 | Start Trial | |||
| China | 101068547 | Start Trial | |||
| China | 102988365 | Start Trial | |||
| European Patent Office | 1819336 | Start Trial | |||
| European Patent Office | 2500021 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
